Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Delta: HealthTech Innovators

Delta: HealthTech Innovators artwork

How This MedTech Startup Is Transforming Prostate Cancer Care with AI | Interview with Artera CEO

Jan 30, 202528 minAudio
  • Apple Podcasts
ShareXLinkedInFacebookWhatsAppEmail

In this exclusive interview, discover how Artera, a pioneering MedTech startup, is harnessing AI to revolutionize prostate cancer treatment and reshape the future of personalized medicine. Join me, Dr. Roupen - a physician and oncologist passionate about healthcare innovation - as I chat with Artera’s CEO, Dr. Andre Esteva. Learn how their AI-driven tests, validated by rigorous clinical trials and supported by major investors like Marc Benioff, are changing the game for both clinicians and patients. We explore how Artera secured insurance reimbursement, overcame the biggest hurdles in HealthTech, and integrated seamlessly into clinical workflows. Dr. Esteva also shares powerful insights on building cross-functional teams, fostering values-based organizational culture, and scaling efficiently in the ever-challenging startup landscape. If you’re excited about AI in Healthcare, Cancer Therapy, and digital health breakthroughs, this episode is a must-watch. Don’t miss these invaluable lessons on turning cutting-edge research into a market-ready product that truly elevates patient outcomes. Subscribe now for more inspiring conversations with industry leaders who are making a real delta in healthcare! Roupen Odabashian: LinkedIn: / roupen-odabashian-183aaa142 X: / roupenmd Email: roupen@deltahealth.tech Andre Esteva LinkedIn: https://www.linkedin.com/in/andre-esteva-phd-ab6b2438/ 0:00 - Introduction: Collaboration in healthcare innovation 0:42 - Guest Introduction: Dr. Andre Esteva, CEO of Artera 1:20 - Artera AI Prostate Test: Transforming cancer treatment 3:09 - AI’s Early Impact: Detecting melanoma with technology 5:06 - Lessons from Salesforce: Values-based company building 6:49 - Artera’s Core Values: Patient success and efficiency 10:38 - What is Artera?: Revolutionizing personalized medicine 13:07 - AI in Oncology: Unlocking hidden insights in cancer care 14:38 - Validation and Guidelines: NCCN and clinical trials 15:41 - Startup Challenges: Data access and reimbursement hurdles 20:00 - Funding Success: Marc Benioff’s support for Artera 22:40 - Advice for Innovators: Start with a clear clinical vision 27:16 - Closing Thoughts: The future of MedTech innovation Watch Our Podcast at YouTube #MedTech, #HealthTech, #Startup, #AI, #ProstateCancer, #PersonalizedMedicine, #Oncology, #DigitalHealth, #HealthcareInnovation, #AIinHealthcare, #PrecisionMedicine, #HealthcareStartup, #CancerCare, #MedicalAI, #DrRoupen, #Artera, #Innovation, #CancerTherapy, #Entrepreneurship, #techtalk

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. AI Won't Replace Doctors | Othman Laraki, Color Health

    Nov 16, 202645 minAudio

    Othman Laraki, co-founder and CEO of Color Health, on why he believes AI will increase the demand for doctors, and what it takes to run a virtual cancer clinic. In this episode of Delta: HealthTech Innovators, I sit...

    • Apple Podcasts

    Credit the people on this episode

  2. Cancer Care Happens Between Visits | Dr. Kingsley Ndoh, Hurone AI

    Oct 26, 202650 minAudio

    Dr. Kingsley Ndoh, physician and founder and CEO of Hurone AI, on building AI that supports cancer patients in the gaps between visits. In this episode of Delta: HealthTech Innovators, I sit down with Kingsley to talk...

    • Apple Podcasts

    Credit the people on this episode

  3. How OpenEvidence Became a $12 Billion AI Healthcare Giant | Full Breakdown

    Feb 24, 20263 hr 58 minAudio

    OpenEvidence just hit a $12 billion valuation - here's the full story of how it happened. Daniel Nadler sold his first company, Kensho, to S&P Global for $550 million. Then he turned his attention to one of the most...

    • Apple Podcasts

    Credit the people on this episode

  4. How Doximity Built a $9B Monopoly Doctors Actually Love | The Full Story

    Jan 21, 20264 hr 2 minAudio

    In this episode, we dive deep into the incredible story of Doximity - the "LinkedIn for Doctors" that captured 80% of US physicians and became one of healthcare's most under-the-radar success stories. Thank you for the...

    • Apple Podcasts

    Credit the people on this episode

  5. The Doctor Will Text You Now: How Councel Health is Scaling the "Clinician Cockpit" with AI

    Jan 20, 202635 minAudio

    Join us for an insightful conversation with Dr. Rishi Khakhkhar, Chief Medical Officer at Counsel Health, as we explore how this AI-enabled virtual care company is transforming the way patients access healthcare through...

    • Apple Podcasts

    Credit the people on this episode